Physician profile
Dong Wang
NPI 1811420524
$1,446.75
in general payments reported to CMS, 2019-2025
16 companies · $223 in 2025
The $223 reported for 2025 was more than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $32.27 · 2021: $233 · 2022: $371 · 2023: $241 · 2024: $346 · 2025: $223.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $611 · Education: $199.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $611.27 |
| Education | $198.98 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $276.39 | 2022-2025 | Xifaxan |
| Teva Pharmaceuticals USA, INC. | $215.17 | 2020-2024 | |
| Novartis Pharmaceuticals Corporation | $193.26 | 2021-2024 | |
| Abbvie INC. | $164.31 | 2021-2023 | Teflaro, Dalvance |
| Janssen Pharmaceuticals, INC | $109.28 | 2021-2023 | Xarelto |
| La Jolla Pharmaceutical Company | $104.53 | 2021-2023 | Xerava |
| Pfizer INC. | $101.67 | 2021-2024 | |
| Otsuka America Pharmaceutical, INC. | $85.99 | 2025 | Rexulti |
| Boston Scientific Corporation | $38.07 | 2023-2024 | Watchman Flx |
| Novo Nordisk INC | $34.90 | 2020-2023 | |
| Stryker Corporation | $28.55 | 2025 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| E.R. Squibb & Sons, L.L.C. | $23.52 | 2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $23.07 | 2024 | Jardiance |
| Paratek Pharmaceuticals, INC. | $22.96 | 2025 | Nuzyra |
| Astrazeneca Pharmaceuticals Lp | $13.26 | 2021 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Takeda Pharmaceuticals U.S.A., INC. | $11.82 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Dong Wang listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.